Patent intelligence · US
US 6117430
Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same
Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same
Patent details — US 6117430
- Jurisdiction
- US
- Status
- expired
- Grant date
- Sep 12, 2000
- Expiration
- Sep 7, 2020
- Applicant
- BIONORICA ARZNEIMITTEL GMBH
- Claims
- 2
- CPC classes
- A61K, A61K36/00, A61P, A61P43/00
Quick answer
US 6117430 (Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same) is held by BIONORICA ARZNEIMITTEL GMBH. Status: expired. Granted Sep 12, 2000. Expires Sep 7, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIONORICA ARZNEIMITTEL GMBH
- Grant date
- Expiration
- Claims
- 2
- CPC classes
- A61K, A61K36/00, A61P, A61P43/00
More from BIONORICA ARZNEIMITTEL GMBH
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 6117430?
US 6117430 (Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same) is held by BIONORICA ARZNEIMITTEL GMBH. Status: expired. Granted Sep 12, 2000. Expires Sep 7, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6117430?
BIONORICA ARZNEIMITTEL GMBH is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 6117430 expire?
Our index shows an expiration date of Sep 7, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.